Clinical Trials List
Protocol NumberBayer #: 20993; Bristol Myers Squibb #: CA209-68U
Completed
2021-12-31 - 2023-10-31
Phase III
Terminated1
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
56 participants
-
Global
496 participants
